Ameren vs Evergy
AEE and EVRG side by side, both in combination electric and gas, and other utility. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AEE and EVRG compare
Ameren is the larger company, worth 1.5 times as much as Evergy ($30.6B against $19.8B).
On earnings, Ameren is cheaper: it trades at 19.5× trailing earnings, against 21.8× for Evergy.
Ameren grew revenue faster over the last twelve months (3.8% versus 3.6% for Evergy).
Both pay dividends: Ameren yields 2.7% and Evergy 3.2%.
Evergy scores higher on the StockData Score (7 against 4 for Ameren), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AEE | EVRG |
|---|---|---|
| Size and price | ||
| Market cap | $30.6B | $19.8B |
| Share price | $110.54 | $85.93 |
| Change, 1 year | 8.1% | 11.7% |
| Change, 5 years | 29.3% | 32.4% |
| Beta (5Y) | 0.37 | 0.35 |
| Employees | – | 4,691 |
| StockData Score | ||
| Total score | 4 | 7 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 1 |
| Performance score | 0 | 3 (better) |
| Health score | 0 | 0 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 19.5× (better) | 21.8× |
| P/S | 3.5× | 3.3× (better) |
| P/B | 2.2× | 1.9× (better) |
| EV/EBITDA | 13.7× | 12.1× (better) |
| PEG | 2.18 (better) | 5.70 |
| FCF yield | −4.6% (better) | −7.1% |
| Fair value | $103.62 | $75.82 |
| Margin of safety | −6.7% (better) | −13.3% |
| Growth | ||
| Revenue growth (TTM) | 3.8% (better) | 3.6% |
| Revenue growth, 5Y average | 8.7% (better) | 3.9% |
| Net income growth (TTM) | – | 10.2% |
| EPS growth (TTM) | 24.8% (better) | 8.2% |
| EPS growth, 5Y average | 8.9% (better) | 6.1% |
| Profitability | ||
| Operating margin | 24.9% | 26.2% (better) |
| Net margin | – | 15.2% |
| FCF margin | −16.0% (better) | −23.1% |
| Return on equity | – | 9.2% |
| Return on invested capital | 5.9% | 6.4% (better) |
| Financial health | ||
| Debt / equity | 1.59 | 1.35 (better) |
| Net debt / EBITDA | 5.68 | 4.94 (better) |
| Interest coverage | 2.6× (better) | 2.5× |
| Current ratio | 0.53 (better) | 0.36 |
| Altman Z-score | 0.90 (better) | 0.79 |
| Piotroski F-score | – | 3 |
| Dividends and buybacks | ||
| Dividend yield | 2.7% | 3.2% (better) |
| Payout ratio | – | 67.4% |
| Years of dividend growth | 12 (better) | 9 |
| Dividend growth, 5Y average | 7.3% (better) | 5.6% |
| Buyback yield | −1.9% | −0.01% (better) |
| Shareholder yield | 0.81% | 3.2% (better) |
| Ownership | ||
| Held by institutions | 88.5% | 94.5% |
| Held by insiders | 0.36% | 1.3% |
| Insider net buying, 12 months | −$8.7M | −$1.7M (better) |
| Short interest, % of float | 5.2% | 8.1% |
Go deeper
- AEE stock overview
- AEE income statement
- AEE valuation and score
- EVRG stock overview
- EVRG income statement
- EVRG valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.